-
1
-
-
70349255612
-
Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of b blockers using a new mechanism-based PK-PD modelling approach
-
van Steeg TJ, Boralli VB, Krekels EHJ et al. Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of b blockers using a new mechanism-based PK-PD modelling approach. J. Pharm. Sci. 98(10) 3816-3828 (2009
-
(2009)
J. Pharm. Sci
, vol.98
, Issue.10
, pp. 3816-3828
-
-
Van Steeg, T.J.1
Boralli, V.B.2
Krekels, E.H.J.3
-
2
-
-
58149180223
-
Some features of the kinetics and equilibrium of drug binding to plasma proteins
-
Berezhkovskiy LM. Some features of the kinetics and equilibrium of drug binding to plasma proteins. Expert Opin. Drug Metab. Toxicol. 4(12), 1479-1498 (2008
-
(2008)
Expert Opin. Drug Metab. Toxicol
, vol.4
, Issue.12
, pp. 1479-1498
-
-
Berezhkovskiy, L.M.1
-
5
-
-
0031472928
-
Species differences of serum albumins: I drug binding sites
-
Kosa T, Maruyama T, Otagiri M. Species differences of serum albumins: I. Drug binding sites. Pharm. Res. 14(11), 1607-1612 (1997
-
(1997)
Pharm. Res
, vol.14
, Issue.11
, pp. 1607-1612
-
-
Kosa, T.1
Maruyama, T.2
Otagiri, M.3
-
6
-
-
0034894719
-
Human alpha-1-glycoprotein and its interactions with drugs
-
Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab. Rev. 33(2), 161-235 (2001
-
(2001)
Drug Metab. Rev
, vol.33
, Issue.2
, pp. 161-235
-
-
Israili, Z.H.1
Dayton, P.G.2
-
7
-
-
0036155217
-
Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine
-
Li J-H, Xu J-Q, Cao X-M et al. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine. Clin. Chim. Acta 317(1-2), 85-92 (2002
-
(2002)
Clin. Chim. Acta
, vol.317
, Issue.1-2
, pp. 85-92
-
-
Li, J.-H.1
Xu, J.-Q.2
Cao, X.-M.3
-
8
-
-
0027234379
-
Evidence for differences in binding of drugs to the two main genetic variants of a1-acid glycoprotein
-
Herve F, Gomas E, Duche JC, Tillement JP. Evidence for differences in binding of drugs to the two main genetic variants of a1-acid glycoprotein. Br. J. Clin. Pharm. 36(3), 241-249 (1993
-
(1993)
Br. J. Clin. Pharm
, vol.36
, Issue.3
, pp. 241-249
-
-
Herve, F.1
Gomas, E.2
Duche, J.C.3
Tillement, J.P.4
-
9
-
-
33749351417
-
Stereoselective pharmacokinetics of cetirazine in the guinea pig: Role of protein binding
-
Gupta A, Hammarlund-Udenaes M, Chatelain P, Massingham R, Jonsson EN. Stereoselective pharmacokinetics of cetirazine in the guinea pig: Role of protein binding. Biopharm. Drug Dispos. 27(6), 291-297 (2006
-
(2006)
Biopharm. Drug Dispos
, vol.27
, Issue.6
, pp. 291-297
-
-
Gupta, A.1
Hammarlund-Udenaes, M.2
Chatelain, P.3
Massingham, R.4
Jonsson, E.N.5
-
10
-
-
13844250391
-
Enantioselective Pharmacokinetics of ibuprofen and involved mechanisms
-
Hao H, Wang G, Sun J. Enantioselective Pharmacokinetics of ibuprofen and involved mechanisms. Drug Metab. Rev. 37(1), 215-234 (2005
-
(2005)
Drug Metab. Rev
, vol.37
, Issue.1
, pp. 215-234
-
-
Hao, H.1
Wang, G.2
Sun, J.3
-
11
-
-
0035717211
-
Chiral separation by chromatographic and electromigration techniques: A review
-
Gübitz G, Schmid MG. Chiral separation by chromatographic and electromigration techniques: A review. Biopharm. Drug Dispos. 22(7-8), 291-336 (2001
-
(2001)
Biopharm. Drug Dispos
, vol.22
, Issue.7-8
, pp. 291-336
-
-
Gübitz, G.1
Schmid, M.G.2
-
12
-
-
33845514543
-
Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management
-
Dasgupta A. Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management. Clin. Chim. Acta 377(1-2), 1-13 (2007
-
(2007)
Clin. Chim. Acta
, vol.377
, Issue.1-2
, pp. 1-13
-
-
Dasgupta, A.1
-
13
-
-
0345698742
-
The significance of lipoproteins in serum binding variations of propofol
-
Zamacona MK, Suarez E, Garcia E, Aguirre C, Calvo R. The significance of lipoproteins in serum binding variations of propofol. Anesth. Analg. 87(5), 1147-1151 (1998
-
(1998)
Anesth. Analg
, vol.87
, Issue.5
, pp. 1147-1151
-
-
Zamacona, M.K.1
Suarez, E.2
Garcia, E.3
Aguirre, C.4
Calvo, R.5
-
14
-
-
0031901271
-
Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs
-
Wasan KM, Cassidy SM. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J. Pharm. Sci. 87(4), 411-424 (1998
-
(1998)
J. Pharm. Sci
, vol.87
, Issue.4
, pp. 411-424
-
-
Wasan, K.M.1
Cassidy, S.M.2
-
15
-
-
33745944468
-
Characterization of drug-binding levels to serum albumin using a wavelength modulation surface plasmon resonance sensor
-
Liu X, Song D, Zhang Q, Tian Y, Liu Z, Zhang H. Characterization of drug-binding levels to serum albumin using a wavelength modulation surface plasmon resonance sensor. Sens. Actuators B Chem. 117(1), 188-195 (2006
-
(2006)
Sens. Actuators B Chem
, vol.117
, Issue.1
, pp. 188-195
-
-
Liu, X.1
Song, D.2
Zhang, Q.3
Tian, Y.4
Liu, Z.5
Zhang, H.6
-
16
-
-
79953665313
-
Characterization of drug interactions with serum proteins by using high performance affinity chromatography
-
Hage DS, Anguizola J, Barnaby O et al. Characterization of drug interactions with serum proteins by using high performance affinity chromatography. Curr. Drug Metab. 12(4), 313-328 (2011
-
(2011)
Curr. Drug Metab
, vol.12
, Issue.4
, pp. 313-328
-
-
Hage, D.S.1
Anguizola, J.2
Barnaby, O.3
-
17
-
-
84871773262
-
High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions
-
Vuignier K, Guillarme D, Veuthey JL, Carrupt PA, Schappler J. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions. J. Pharm. Biomed. Anal. 74, 205-212 (2013
-
(2013)
J. Pharm. Biomed. Anal
, vol.74
, pp. 205-212
-
-
Vuignier, K.1
Guillarme, D.2
Veuthey, J.L.3
Carrupt, P.A.4
Schappler, J.5
-
18
-
-
33645971661
-
The role of unbound drug in pharmacokinetics/pharmacodynamics and in therapy
-
Calvo R, Lukas JC, Rodriguez M, Leal N, Suarez E. The role of unbound drug in pharmacokinetics/pharmacodynamics and in therapy. Curr. Pharm. Des. 12(8), 977-987 (2006
-
(2006)
Curr. Pharm. Des
, vol.12
, Issue.8
, pp. 977-987
-
-
Calvo, R.1
Lukas, J.C.2
Rodriguez, M.3
Leal, N.4
Suarez, E.5
-
19
-
-
78649706279
-
The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery
-
Smith DA, Di L, Kerns EH. The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery. Nature Rev. Drug Discov. 9(12), 929-939 (2010
-
(2010)
Nature Rev. Drug Discov
, vol.9
, Issue.12
, pp. 929-939
-
-
Smith, D.A.1
Di L Kerns, E.H.2
-
20
-
-
0036908023
-
Free drug fraction vs free drug concentration: A matter of frequent confusion
-
Toutain PL, Bousquet-Melou A. Free drug fraction vs free drug concentration: A matter of frequent confusion. J. Vet. Pharmacol. Ther. 25(6), 460-463 (2002
-
(2002)
J. Vet. Pharmacol. Ther
, vol.25
, Issue.6
, pp. 460-463
-
-
Toutain, P.L.1
Bousquet-Melou, A.2
-
22
-
-
0036218554
-
Changes in plasma protein binding has little clinical relevance
-
Benet LZ, Hoener BA. Changes in plasma protein binding has little clinical relevance. Clin. Pharmacol. Ther. 71(3), 115-121 (2002
-
(2002)
Clin. Pharmacol. Ther
, vol.71
, Issue.3
, pp. 115-121
-
-
Benet, L.Z.1
Hoener, B.A.2
-
23
-
-
84873050688
-
The clinical relevance of plasma protein binding changes
-
Roberts JA, Pea F, Lipman J. The clinical relevance of plasma protein binding changes. Clin. Pharmacokinet. 52(1), 1-8 (2013
-
(2013)
Clin. Pharmacokinet
, vol.52
, Issue.1
, pp. 1-8
-
-
Roberts, J.A.1
Pea, F.2
Lipman, J.3
-
24
-
-
76649085489
-
Significance of protein binding in pharmacokinetics and pharmacodynamics
-
Schmidt S, Gonzalez D, Derendorf H. Significance of protein binding in pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 99(3), 1107-1122 (2010
-
(2010)
J. Pharm. Sci
, vol.99
, Issue.3
, pp. 1107-1122
-
-
Schmidt, S.1
Gonzalez, D.2
Derendorf, H.3
-
25
-
-
79551662332
-
Do we need to optimize plasma protein binding and tissue binding in drug discovery?
-
Liu X, Chen C, Hop CE. Do we need to optimize plasma protein binding and tissue binding in drug discovery? Curr. Top. Med. Chem. 11(4), 450-466 (2011
-
(2011)
Curr. Top. Med. Chem
, vol.11
, Issue.4
, pp. 450-466
-
-
Liu, X.1
Chen, C.2
Hop, C.E.3
-
26
-
-
0029922030
-
Drug protein binding studies New trends in analytical and experimental methodology
-
Oravcová J, Böhs B, Lindner W. Drug protein binding studies. New trends in analytical and experimental methodology. J. Chromatogr. B 677(1), 1-28 (1996
-
(1996)
J. Chromatogr
, vol.B 677
, Issue.1
, pp. 1-28
-
-
Oravcová, J.1
Böhs, B.2
Lindner, W.3
-
27
-
-
7444236750
-
Measurement of free concentrations using negligible depletion-solid phase microextraction (nd-SPME
-
Heringa MB, Hermens JLM. Measurement of free concentrations using negligible depletion-solid phase microextraction (nd-SPME). Trends Anal. Chem. 22(10), 575-587 (2003
-
(2003)
Trends Anal. Chem
, vol.22
, Issue.10
, pp. 575-587
-
-
Heringa, M.B.1
Hermens, J.L.M.2
-
28
-
-
0032897673
-
High-performance frontal analysis for drug-protein binding study
-
Shibukawa A, Kuroda Y, Nagakawa T. High-performance frontal analysis for drug-protein binding study. J. Pharm. Biomed. Anal. 18(6), 1047-1055 (1999
-
(1999)
J. Pharm. Biomed. Anal
, vol.18
, Issue.6
, pp. 1047-1055
-
-
Shibukawa, A.1
Kuroda, Y.2
Nagakawa, T.3
-
29
-
-
77955933364
-
Drug-protein binding: A critical review of analytical tools
-
Vuignier K, Schappler J, Veuthey JL, Carrupt PA, Martel S. Drug-protein binding: A critical review of analytical tools. Anal. Bioanal. Chem. 398(1), 53-66 (2010
-
(2010)
Anal. Bioanal. Chem
, vol.398
, Issue.1
, pp. 53-66
-
-
Vuignier, K.1
Schappler, J.2
Veuthey, J.L.3
Carrupt, P.A.4
Martel, S.5
-
30
-
-
80051694070
-
Monitoring free drug concentrations: Challenges
-
Musteata FM. Monitoring free drug concentrations: Challenges. Bioanalysis 3(15), 1753-1768 (2011
-
(2011)
Bioanalysis
, vol.3
, Issue.15
, pp. 1753-1768
-
-
Musteata, F.M.1
-
31
-
-
84862828843
-
Compilation of 222 drugs plasma protein binding data and guidance for study design
-
Zhang F, Xue J, Shao J, Jia L. Compilation of 222 drugs plasma protein binding data and guidance for study design. Drug Discov. Today 17(9-10), 475-485 (2012
-
(2012)
Drug Discov. Today
, vol.17
, Issue.9-10
, pp. 475-485
-
-
Zhang, F.1
Xue, J.2
Shao, J.3
Jia, L.4
-
32
-
-
84879193775
-
QSAR models for the prediction of plasma protein binding
-
Ghafourian T, Amin Z. QSAR models for the prediction of plasma protein binding. Bioimpacts 3(1), 21-27 (2013
-
(2013)
Bioimpacts
, vol.3
, Issue.1
, pp. 21-27
-
-
Ghafourian, T.1
Amin, Z.2
-
33
-
-
60749101939
-
Plasma/serum protein binding determinations
-
Banker MJ, Clark TH. Plasma/serum protein binding determinations. Curr. Drug Metab. 9(9), 854-859 (2008
-
(2008)
Curr. Drug Metab
, vol.9
, Issue.9
, pp. 854-859
-
-
Banker, M.J.1
Clark, T.H.2
-
34
-
-
33749434494
-
Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization
-
Zhang J, Musson DG. Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization. J. Chromatogr. B 843(1), 47-56 (2006
-
(2006)
J. Chromatogr
, vol.B 843
, Issue.1
, pp. 47-56
-
-
Zhang, J.1
Musson, D.G.2
-
35
-
-
0017887843
-
Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out
-
Sophianopoulos JA, Durham SJ, Sophianopoulos AJ, Ragsdale HL, Cropper WP. Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out. Arch. Biochem. Biophys. 187(1), 132-137 (1978
-
(1978)
Arch. Biochem. Biophys
, vol.187
, Issue.1
, pp. 132-137
-
-
Sophianopoulos, J.A.1
Durham, S.J.2
Sophianopoulos, A.J.3
Ragsdale, H.L.4
Cropper, W.P.5
-
36
-
-
0019944388
-
Free drug concentrations are constant in serial fractions of plasma ultrafiltrate
-
Judd RL, Pesce AJ. Free drug concentrations are constant in serial fractions of plasma ultrafiltrate. Clin. Chem. 28(7), 1726-1727 (1982
-
(1982)
Clin. Chem
, vol.28
, Issue.7
, pp. 1726-1727
-
-
Judd, R.L.1
Pesce, A.J.2
-
37
-
-
26444541994
-
Effect of ultrafiltrate volume on determination of free phenytoin concentrations
-
McMillin GA, Juenke J, Dasgupta A. Effect of ultrafiltrate volume on determination of free phenytoin concentrations. Ther. Drug Monit. 27(5), 630-633 (2005
-
(2005)
Ther. Drug Monit
, vol.27
, Issue.5
, pp. 630-633
-
-
McMillin, G.A.1
Juenke, J.2
Dasgupta, A.3
-
38
-
-
84871419978
-
Effect of volume ratio of ultrafiltrate to sample solution on the analysis of free drug and measurement of free carbamazepine in clinical drug monitoring
-
Dong W, Zhang Z, Liang X, Sun Y, Jiang Y. Effect of volume ratio of ultrafiltrate to sample solution on the analysis of free drug and measurement of free carbamazepine in clinical drug monitoring. Eur. J. Pharm. Sci. 48(1-2), 332-338 (2013
-
(2013)
Eur. J. Pharm. Sci
, vol.48
, Issue.1-2
, pp. 332-338
-
-
Dong, W.1
Zhang, Z.2
Liang, X.3
Sun, Y.4
Jiang, Y.5
-
39
-
-
84871735543
-
A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds
-
Wang C, Williams NS. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. J. Pharm. Biomed. Anal. 75, 112-117 (2013
-
(2013)
J. Pharm. Biomed. Anal
, vol.75
, pp. 112-117
-
-
Wang, C.1
Williams, N.S.2
-
40
-
-
0038198608
-
Modulation of non-specific binding in ultrafiltration protein binding studies
-
Lee K-J, Mower R, Hollenbeck T et al. Modulation of non-specific binding in ultrafiltration protein binding studies. Pharm. Res. 20(7), 1015-1021 (2003
-
(2003)
Pharm. Res
, vol.20
, Issue.7
, pp. 1015-1021
-
-
Lee, K.-J.1
Mower, R.2
Hollenbeck, T.3
-
41
-
-
33645045860
-
Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticostereoids
-
Taylor S, Harker A. Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticostereoids. J. Pharm. Biomed. Anal. 41(1), 299-303 (2006
-
(2006)
J. Pharm. Biomed. Anal
, vol.41
, Issue.1
, pp. 299-303
-
-
Taylor, S.1
Harker, A.2
-
42
-
-
81855173594
-
Correction for nonspecific binding to various components of ultrafiltration apparatus and impact on estimating in vivo rat clearance for a congeneric series of 5-ethyl, 5-n-alkyl barbituric acids
-
Ballard P, Rowland M. Correction for nonspecific binding to various components of ultrafiltration apparatus and impact on estimating in vivo rat clearance for a congeneric series of 5-ethyl, 5-n-alkyl barbituric acids. Drug Metab. Dispos. 39(12), 2165-2168 (2011
-
(2011)
Drug Metab. Dispos
, vol.39
, Issue.12
, pp. 2165-2168
-
-
Ballard, P.1
Rowland, M.2
-
43
-
-
79954501848
-
Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs
-
Zamek-Gliszczynski MJ, Ruterbories KJ, Ajamie RT et al. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs. J. Pharm. Sci. 100(6), 2498-2507 (2011
-
(2011)
J. Pharm. Sci
, vol.100
, Issue.6
, pp. 2498-2507
-
-
Zamek-Gliszczynski, M.J.1
Ruterbories, K.J.2
Ajamie, R.T.3
-
44
-
-
0035091313
-
Simultaneous determination of total and free drug plasma concentrations combined with batch-wise pH-adjustment for the free concentration determinations
-
Nilsson LB, Schmidt S. Simultaneous determination of total and free drug plasma concentrations combined with batch-wise pH-adjustment for the free concentration determinations. J. Pharm. Biomed. Anal. 24(5-6), 921-927 (2001
-
(2001)
J. Pharm. Biomed. Anal
, vol.24
, Issue.5-6
, pp. 921-927
-
-
Nilsson, L.B.1
Schmidt, S.2
-
45
-
-
0142217486
-
Shift of pH of biological fluids during storage and processing: Effect on bioanalysis
-
Fura A, Harper TW, Zhang H, Fung L, Shyu WC. Shift of pH of biological fluids during storage and processing: Effect on bioanalysis. J. Pharm. Biomed. Anal. 32(3), 513-522 (2003
-
(2003)
J. Pharm. Biomed. Anal
, vol.32
, Issue.3
, pp. 513-522
-
-
Fura, A.1
Harper, T.W.2
Zhang, H.3
Fung, L.4
Shyu, W.C.5
-
46
-
-
13244250954
-
The pH dependency of the binding of drugs to plasma proteins in man
-
Hinderling PH, Hartmann D. The pH dependency of the binding of drugs to plasma proteins in man. Ther. Drug Monit. 27(1), 71-85 (2005
-
(2005)
Ther. Drug Monit
, vol.27
, Issue.1
, pp. 71-85
-
-
Hinderling, P.H.1
Hartmann, D.2
-
47
-
-
46449118907
-
Impact of pH on plasma protein binding in equilibrium dialysis
-
Kochansky CJ, McMasters DR, Lu P et al. Impact of pH on plasma protein binding in equilibrium dialysis. Mol. Pharm. 5(3), 438-448 (2008
-
(2008)
Mol. Pharm
, vol.5
, Issue.3
, pp. 438-448
-
-
Kochansky, C.J.1
McMasters, D.R.2
Lu, P.3
-
48
-
-
0018803472
-
Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements
-
Wilting J, Weideman MM, Roomer ACJ, Perrin JH. Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements. Biochim. Biophys. Acta 579(2), 469-473 (1979
-
(1979)
Biochim. Biophys. Acta
, vol.579
, Issue.2
, pp. 469-473
-
-
Wilting, J.1
Weideman, M.M.2
Roomer, A.C.J.3
Perrin, J.H.4
-
49
-
-
0033045696
-
Interactive binding to the two principal ligand binding sites of human serum albumin: Effect of the neutral-to-base transition
-
Yamasaki K, Maruyama T, Yoshimoto K et al. Interactive binding to the two principal ligand binding sites of human serum albumin: Effect of the neutral-to-base transition. Biochim. Biophys. Acta 1432(2), 313-323 (1999
-
(1999)
Biochim. Biophys. Acta
, vol.1432
, Issue.2
, pp. 313-323
-
-
Yamasaki, K.1
Maruyama, T.2
Yoshimoto, K.3
-
50
-
-
0024593566
-
Drug binding to a1-acid glycoprotein studied by circular dichroism
-
Otagiri M, Yamanichi R, Maruyama T et al. Drug binding to a1-acid glycoprotein studied by circular dichroism. Pharm. Res. 6(2), 156-159 (1989
-
(1989)
Pharm. Res
, vol.6
, Issue.2
, pp. 156-159
-
-
Otagiri, M.1
Yamanichi, R.2
Maruyama, T.3
-
51
-
-
0025942640
-
PH-dependency of basic ligand binding to a1-acid glycoprotein (orosomucoid
-
Urien S, Bree F, Testa B, Tillement J-P. pH-dependency of basic ligand binding to a1-acid glycoprotein (orosomucoid). Biochem. J. 280(Pt 1), 277-280 (1991
-
(1991)
Biochem. J
, vol.280
, Issue.PART 1
, pp. 277-280
-
-
Urien, S.1
Bree, F.2
Testa, B.3
Tillement, J.-P.4
-
52
-
-
0034308903
-
Evaluation of solid-phase microextraction for the study of protein binding in human plasma samples
-
Abdel-Rehim M, Carlsson C, Bielenstein M, Arvidsson T, Blomberg LG. Evaluation of solid-phase microextraction for the study of protein binding in human plasma samples. J. Chromatogr. Sci. 38(10), 458-464 (2000
-
(2000)
J. Chromatogr. Sci
, vol.38
, Issue.10
, pp. 458-464
-
-
Abdel-Rehim, M.1
Carlsson, C.2
Bielenstein, M.3
Arvidsson, T.4
Blomberg, L.G.5
-
53
-
-
0034953125
-
Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy
-
Kodama H, Kodama Y, Itokazu N, Shinozawa S, Kanemaru R, Sugimoto T. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy. J. Clin. Pharm. Ther. 26(3), 175-179 (2001
-
(2001)
J. Clin. Pharm. Ther
, vol.26
, Issue.3
, pp. 175-179
-
-
Kodama, H.1
Kodama, Y.2
Itokazu, N.3
Shinozawa, S.4
Kanemaru, R.5
Sugimoto, T.6
-
54
-
-
0034511743
-
Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative
-
Moon YJ, Kim SH, Ryu CK, Lee MG. Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative. Res. Commun. Mol. Pathol. Pharmacol. 108(2-3), 167-177 (2000
-
(2000)
Res. Commun. Mol. Pathol. Pharmacol
, vol.108
, Issue.2-3
, pp. 167-177
-
-
Moon, Y.J.1
Kim, S.H.2
Ryu, C.K.3
Lee, M.G.4
-
55
-
-
29044432751
-
High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry
-
Wan H, Rehngren M. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry. J. Chromatogr. A 1102(1-2), 125-134 (2006
-
(2006)
J. Chromatogr
, vol.A 1102
, Issue.1-2
, pp. 125-134
-
-
Wan, H.1
Rehngren, M.2
-
56
-
-
65449136735
-
Characterization of drug-protein interactions in blood using high-performance affinity chromatography
-
Hage DS, Jackson A, Sobansky MR, Schiel JE, Yoo MJ, Joseph KS. Characterization of drug-protein interactions in blood using high-performance affinity chromatography. J. Sep. Sci. 32(5-6), 835-853 (2009
-
(2009)
J. Sep. Sci
, vol.32
, Issue.5-6
, pp. 835-853
-
-
Hage, D.S.1
Jackson, A.2
Sobansky, M.R.3
Schiel, J.E.4
Yoo, M.J.5
Joseph, K.S.6
-
58
-
-
79951913810
-
Control and measurement of plasma pH in equilibrium dialysis: Influence on drug plasma protein binding
-
Curran RE, Claxton CRJ, Hutchison L, Harradine PJ, Martin IJ, Littlewood P. Control and measurement of plasma pH in equilibrium dialysis: Influence on drug plasma protein binding. Drug Metab. Dispos. 39(3), 551-557 (2011
-
(2011)
Drug Metab. Dispos
, vol.39
, Issue.3
, pp. 551-557
-
-
Curran, R.E.1
Claxton, C.R.J.2
Hutchison, L.3
Harradine, P.J.4
Martin, I.J.5
Littlewood, P.6
-
59
-
-
33847678183
-
On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: Determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein
-
Berezhkovskiy LM. On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: Determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein. J. Pharm. Sci. 96(2), 249-257 (2007
-
(2007)
J. Pharm. Sci
, vol.96
, Issue.2
, pp. 249-257
-
-
Berezhkovskiy, L.M.1
-
60
-
-
59849123581
-
Consideration of the linear concentration increase of the unbound drug fraction in plasma
-
Berezhkovskiy LM. Consideration of the linear concentration increase of the unbound drug fraction in plasma. J. Pharm. Sci. 98(2), 383-393 (2009
-
(2009)
J. Pharm. Sci
, vol.98
, Issue.2
, pp. 383-393
-
-
Berezhkovskiy, L.M.1
-
61
-
-
0029889951
-
Measurement and analysis of unbound drug concentrations
-
Wright JD, Boudinot FD, Ujhelyi MR. Measurement and analysis of unbound drug concentrations. Clin. Pharmacokinet. 30(6), 445-462 (1996
-
(1996)
Clin. Pharmacokinet
, vol.30
, Issue.6
, pp. 445-462
-
-
Wright, J.D.1
Boudinot, F.D.2
Ujhelyi, M.R.3
-
62
-
-
2942610651
-
Pharmaceutical-grade albumin: Impaired drug-binding capacity in vitro
-
Olsen H, Andersen A, Nordbo U, Kongsgaard UE, Bormer OP. Pharmaceutical-grade albumin: Impaired drug-binding capacity in vitro. BMC Clin. Pharmacol. 4, 4 (2004
-
(2004)
BMC Clin. Pharmacol
, vol.4
, pp. 4
-
-
Olsen, H.1
Andersen, A.2
Nordbo, U.3
Kongsgaard, U.E.4
Bormer, O.P.5
-
63
-
-
0344267753
-
Serum protein binding of tolteridine and its major mertabolites in humans and several animal species
-
Påhlman I, Gozzi P. Serum protein binding of tolteridine and its major mertabolites in humans and several animal species. Biopharm. Drug Dispos. 20(2), 91-99 (1999
-
(1999)
Biopharm. Drug Dispos
, vol.20
, Issue.2
, pp. 91-99
-
-
Påhlman, I.1
Gozzi, P.2
-
64
-
-
26444483440
-
Stabilizing drug molecules in biological samples
-
Chen J, Hsieh Y. Stabilizing drug molecules in biological samples. Ther. Drug Monit. 27(5), 617-624 (2005
-
(2005)
Ther. Drug Monit
, vol.27
, Issue.5
, pp. 617-624
-
-
Chen, J.1
Hsieh, Y.2
-
65
-
-
77952258130
-
Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor
-
Eng H, McDonald TS, Wolford A et al. Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor. Xenobiotica 40(6), 369-380 (2010
-
(2010)
Xenobiotica
, vol.40
, Issue.6
, pp. 369-380
-
-
Eng, H.1
McDonald, T.S.2
Wolford, A.3
-
66
-
-
78650643244
-
Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC-MS/M.S
-
Fung EN, Zheng N, Arnold ME, Zeng J. Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC-MS/MS. Bioanalysis 2(4), 733-743 (2010
-
(2010)
Bioanalysis
, vol.2
, Issue.4
, pp. 733-743
-
-
Fung, E.N.1
Zheng, N.2
Arnold, M.E.3
Zeng, J.4
-
67
-
-
70449526714
-
Improving ex vivo stability of drug ester compounds in rat and dog serum: Inhibition of the specific esterase and implications on their identity
-
Koitka M, Höchel J, Gieschen H, Borchert H-H. Improving ex vivo stability of drug ester compounds in rat and dog serum: Inhibition of the specific esterase and implications on their identity. J. Pharm. Biomed. Anal. 51, 664-678 (2010
-
(2010)
J. Pharm. Biomed. Anal
, vol.51
, pp. 664-678
-
-
Koitka, M.1
Höchel, J.2
Gieschen, H.3
Borchert, H.-H.4
-
68
-
-
79953176303
-
A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril
-
Wenlock MC, Barton P, Austin RP. A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril. J. Pharm. Biomed. Anal. 55(3), 385-390 (2011
-
(2011)
J. Pharm. Biomed. Anal
, vol.55
, Issue.3
, pp. 385-390
-
-
Wenlock, M.C.1
Barton, P.2
Austin, R.P.3
-
69
-
-
82455180410
-
Turbulent flow liquid chromatography tandem mass spectrometry for the analysis of bioavailable testosterone in serum
-
Wright M, Couchman L, Halsall D. Turbulent flow liquid chromatography tandem mass spectrometry for the analysis of bioavailable testosterone in serum. Endocrine Abstracts 25, P29 (2011
-
(2011)
Endocrine Abstracts
, vol.25
, pp. 29
-
-
Wright, M.1
Couchman, L.2
Halsall, D.3
-
70
-
-
33750699643
-
Analysis of free drug fractions using near infrared fluorescent labels and an ultrafast immunoextraction/displacement assay
-
Ohnmacht CN, Schiel JE, Hage DS. Analysis of free drug fractions using near infrared fluorescent labels and an ultrafast immunoextraction/displacement assay. Anal. Chem. 78(21), 7547-7556 (2006
-
(2006)
Anal. Chem
, vol.78
, Issue.21
, pp. 7547-7556
-
-
Ohnmacht, C.N.1
Schiel, J.E.2
Hage, D.S.3
-
71
-
-
83655190961
-
Development of a flow based ultrafast immunoextraction and reverse displacement immunoassay: Analysis of free drug fractions
-
Schiel JE, Tong Z, Sakulthaew C, Hage DS. Development of a flow based ultrafast immunoextraction and reverse displacement immunoassay: Analysis of free drug fractions. Anal. Chem. 83(24), 9384-9390 (2011
-
(2011)
Anal. Chem
, vol.83
, Issue.24
, pp. 9384-9390
-
-
Schiel, J.E.1
Tong, Z.2
Sakulthaew, C.3
Hage, D.S.4
-
72
-
-
0036007254
-
Stability of 11-nor-D9-carboxytetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry
-
Skopp G, Pötsch L. Stability of 11-nor-D9- carboxytetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin. Chem. 48(2), 301-306 (2002
-
(2002)
Clin. Chem
, vol.48
, Issue.2
, pp. 301-306
-
-
Skopp, G.1
Pötsch, L.2
-
73
-
-
0027154750
-
Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry
-
Ding A, Ojingwa JC, McDonagh AF, Burlingame AL, Benet LZ. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc. Natl Acad. Sci. USA 90(9), 3979-3801 (1993
-
(1993)
Proc. Natl Acad. Sci. USA
, vol.90
, Issue.9
, pp. 3979-3801
-
-
Ding, A.1
Ojingwa, J.C.2
McDonagh, A.F.3
Burlingame, A.L.4
Benet, L.Z.5
-
74
-
-
79959861661
-
Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry
-
Deng Y, Wong H, Graham RA et al. Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry. J. Chromatogr. B 879(22), 2119-2126 (2011
-
(2011)
J. Chromatogr
, vol.B 879
, Issue.22
, pp. 2119-2126
-
-
Deng, Y.1
Wong, H.2
Graham, R.A.3
-
75
-
-
1842482952
-
High-throughput determination of the free fraction of drugs strongly bound to plasma proteins
-
Schumacher J, Kohlsdorfer C, Bühner K, Brandenburger T, Kruk R. High-throughput determination of the free fraction of drugs strongly bound to plasma proteins. J. Pharm. Sci. 93(4), 816-830 (2004
-
(2004)
J. Pharm. Sci
, vol.93
, Issue.4
, pp. 816-830
-
-
Schumacher, J.1
Kohlsdorfer, C.2
Bühner, K.3
Brandenburger, T.4
Kruk, R.5
-
76
-
-
0036708022
-
Evaluation of highly bound drugs; interspecies, intersubject and related comparisons
-
Collins JM, Klecker RW. Evaluation of highly bound drugs; interspecies, intersubject and related comparisons. J. Clin. Pharmacol. 42(9), 971-975 (2002
-
(2002)
J. Clin. Pharmacol
, vol.42
, Issue.9
, pp. 971-975
-
-
Collins, J.M.1
Klecker, R.W.2
-
77
-
-
19544368019
-
Studies of drug binding to plasma proteins using a variant of equilibrium dialysis
-
Eriksson MAL, Gabrielsson J, Nilsson LB. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis. J. Pharm. Biomed. Anal. 38(3), 381-389 (2005
-
(2005)
J. Pharm. Biomed. Anal
, vol.38
, Issue.3
, pp. 381-389
-
-
Eriksson, M.A.L.1
Gabrielsson, J.2
Nilsson, L.B.3
-
78
-
-
0031404916
-
Heat treatment to inactivate HIV does not alter protein binding of selected drugs
-
Mosley AK, Brouwer KLR. Heat treatment to inactivate HIV does not alter protein binding of selected drugs. Ther. Drug Monit. 19(4), 477-479 (1997
-
(1997)
Ther. Drug Monit
, vol.19
, Issue.4
, pp. 477-479
-
-
Mosley, A.K.1
Brouwer, K.L.R.2
-
79
-
-
0023845364
-
Comparative study of inactivation of herpes simplex virus types 1 and 2 by commonly used antiseptic agents
-
Croughan WS, Behbehani AM. Comparative study of inactivation of herpes simplex virus types 1 and 2 by commonly used antiseptic agents. J. Clin. Microbiol. 26(2), 213-215 (1988
-
(1988)
J. Clin. Microbiol
, vol.26
, Issue.2
, pp. 213-215
-
-
Croughan, W.S.1
Behbehani, A.M.2
-
80
-
-
3843135290
-
In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia
-
Kretz O, Weiss HM, Schumacher MM, Gross G. In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia. Br. J. Clin. Pharmacol. 58(2), 212-216 (2004
-
(2004)
Br. J. Clin. Pharmacol
, vol.58
, Issue.2
, pp. 212-216
-
-
Kretz, O.1
Weiss, H.M.2
Schumacher, M.M.3
Gross, G.4
-
81
-
-
0035724321
-
Validation of methods to study the distribution and protein binding of tacrolimus in human blood
-
Zahir H, Nand RA, Brown KF, Tattam BN, McLachlan AJ. Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J. Pharmacol. Toxicol. Methods 46(1), 27-35 (2001
-
(2001)
J. Pharmacol. Toxicol. Methods
, vol.46
, Issue.1
, pp. 27-35
-
-
Zahir, H.1
Nand, R.A.2
Brown, K.F.3
Tattam, B.N.4
McLachlan, A.J.5
-
82
-
-
78649392445
-
Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: Systematic investigation using ultra-high-performance liquid chromatography-mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization
-
Remane D, Meyer MR, Wissenbach DK, Maurer HH. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: Systematic investigation using ultra-high-performance liquid chromatography-mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization. Rapid Commun. Mass Spectrom. 24(21), 3103-3108 (2010
-
(2010)
Rapid Commun. Mass Spectrom
, vol.24
, Issue.21
, pp. 3103-3108
-
-
Remane, D.1
Meyer, M.R.2
Wissenbach, D.K.3
Maurer, H.H.4
-
83
-
-
33749434494
-
Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization
-
Zhang J, Musson DG. Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization. J. Chromatogr. B 843(1), 47-56 (2006
-
(2006)
J. Chromatogr
, vol.B 843
, Issue.1
, pp. 47-56
-
-
Zhang, J.1
Musson, D.G.2
-
84
-
-
79960562681
-
Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/M.S
-
Sillén H, Cook M, Davis P. Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/MS. J. Chromatogr. B 879(23), 2315-2322 (2011
-
(2011)
J. Chromatogr
, vol.B 879
, Issue.23
, pp. 2315-2322
-
-
Sillén, H.1
Cook, M.2
Davis, P.3
|